Ifp Advisors, Inc Karyopharm Therapeutics Inc. Transaction History

Ifp Advisors, Inc

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 06, 2021	SELL	$4.45 - $10.63 $0 - $0	0 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$8.11 - $11.11 $0 - $0	0 New	0 $0
Q1 2021 Apr 30, 2021	BUY	$9.85 - $17.69 $0 - $0	0 New	0 $0
Q4 2020 Jan 25, 2021	BUY	$14.15 - $17.19 $0 - $0	0 New	0 $0
Q3 2020 Oct 29, 2020	BUY	$14.14 - $19.71 $0 - $0	0 New	0 $0
Q2 2020 Aug 05, 2020	BUY	$16.6 - $25.25 $0 - $0	0 New	0 $0
Q1 2020 May 12, 2020	BUY	$14.38 - $27.72 $0 - $0	0 New	0 $0
Q4 2019 Jan 17, 2020	BUY	$9.23 - $19.67 $0 - $0	0 New	0 $0
Q3 2019 Nov 07, 2019	BUY	$5.66 - $11.85 $0 - $0	0 New	0 $0
Q1 2019 May 15, 2019	SELL	$4.12 - $10.25 $23,278 - $57,912	-5,650 Closed	0 $0
Q4 2018 Jan 23, 2019	BUY	$8.2 - $16.95 $30,749 - $63,562	3,750 Added 197.37%	5,650 $52,000
Q3 2018 Oct 25, 2018	BUY	$17.03 - $21.18 $1,703 - $2,118	100 Added 5.56%	1,900 $0
Q2 2018 Aug 07, 2018	BUY	$12.0 - $19.88 $19,800 - $32,802	1,650 Added 1100.0%	1,800 $0
Q4 2016 Jun 03, 2019	SELL	N/A	-500 Reduced 76.92%	150 $1,000
Q2 2016 Jun 03, 2019	BUY	N/A	650	650 $4,000

56.5M

258K

81.2K

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $49.5M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.